Jan 27, 2017 at 14:58 | Source: PTI
The company had posted a net loss of Rs 41.02 crore for the same period of previous fiscal, SPARC said in a regulatory filing.
Dec 22, 2016 at 22:08 | Source: Moneycontrol.com
SP Tulsian of sptulsian.com, talks about why he is bullish on Hindustan Zinc and other non-ferrous metal stocks. He also gives his views on the non-banking financial companies (NBFC).
Dec 22, 2016 at 13:25 | Source: Moneycontrol.com
Shares of Sun Pharma Advanced Research Company, the subsidiary of healthcare major Sun Pharmaceutical, surged nearly 7 percent intraday Thursday after receiving complete response letter from the US health regulator for preservative-free eye drop.
Dec 22, 2016 at 11:00 | Source: Moneycontrol.com
The selling pressure continued for the seventh consecutive session today due to lack of positive triggers. The market may be factoring in the impact of demonetisation on December quarter earnings, December sales data and economic data that will be announced next month.
Dec 22, 2016 at 10:33 | Source: CNBC-TV18
SPARC has received a complete response letter (CRL) from USFDA for their new drug application (NDA) on Xelpros, which is an eye drop studied by SPARC, reports CNBC-TV18.
Nov 01, 2016 at 07:52 | Source: Moneycontrol.com
Gaurav Ratnaparkhi of Sharekhan advises buying CESC with a target of Rs 655.
Oct 28, 2016 at 15:14 | Source: PTI
The company had posted a net loss of Rs 17.74 crore in the corresponding period of the previous fiscal, Sun Pharma Advanced Research Company (SPARC) said in a filing to BSE.
Aug 05, 2016 at 11:13 | Source: CNBC-TV18
Mitesh Thacker of miteshthacker.com is of the view that one may buy Tata Steel and advises selling Infosys.
Aug 05, 2016 at 09:27 | Source: CNBC-TV18
Rajat Bose of rajatkbose.com feels that Cadila Healthcare may test Rs 393.
Aug 04, 2016 at 16:40 | Source: CNBC-TV18
Mitesh Thacker of miteshthacker.com advises buying Sun Pharma Advanced Research Company.